Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis

Timmerman John

首页> 外文期刊>Oncology >Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis

【24h】

Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis

机译：血液癌症打破了“检查点”：以PD-1 / PD-L1轴为目标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology》 |2015年第6期|共2页
作者
Timmerman John;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis [J] . Timmerman John Oncology . 2015,第6期

机译：血液癌症打破了“检查点”：以PD-1 / PD-L1轴为目标
2. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer [J] . Rui Zhang, Zhiyan Zhu, Hongying Lv, Small . 2019,第49期

机译：由小分子纳米烟穴介导的免疫检查点延迟靶向PD-1 / PD-L1途径的促进促进光动力疗法，以引发抗肿瘤免疫和对乳腺癌的抗致抗体作用
3. A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment [J] . Zhou Tian C., Sankin Alexander I., Porcelli Steven A., Urologic oncology . 2017,第1期

机译：膀胱癌PD-1 / PD-L1检查点的综述：从免疫逃逸的介导靶向治疗
4. Molecular dynamics of the immune checkpoint Programmed Cell Death Protein I, PD-1: Conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab [C] . Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：免疫检查点的分子动力学程序性细胞死亡蛋白I，PD-1：配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
5. Immune Checkpoints PD-1/PD-L1 and Natural Killer Cells in Chemo-resistant Colorectal Cancer [D] . Siu, Hon Lam Elaine. 2019

机译：免疫检查点PD-1 / PD-L1和化疗结直肠癌中的天然杀伤细胞
6. Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers [O] . Aaron Prodeus, Aws Abdul-Wahid, Nicholas W. Fischer, 2015

机译：用DNA适体靶向PD-1 / PD-L1免疫逃逸轴作为一种治疗弥散性癌症的新治疗策略
7. Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1 [O] . A. Bayle, M. Khettab, F. Lucibello, 2020

机译：癌症患者患者患者患者靶向PD-1或PD-L1的免疫原性和安全性

Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis

著录项

相似文献

相关主题

期刊订阅